Literature DB >> 10022334

Tiered screening and testing strategy for xenoestrogens and antiandrogens.

L E Gray1.   

Abstract

Anthropogenic chemicals that disrupt endocrine function during critical stages of development can produce profound reproductive alterations in both wildlife and humans. Of the tens of thousands of chemicals in existence, few have been tested for their ability to disrupt the endocrine system. Newly enacted legislation requires that the USEPA develop a chemical screening and testing program for endocrine effects. At present, the Endocrine Disrupters Screening and Testing Advisory Committee (EDSTAC) is considering a screening battery (Tier 1) to detect (anti)estrogenic (E) (anti)androgenic (A) and antithyroid activities using in vivo and in vitro assays. In addition, the battery should detect alterations of hypothalamic-pituitary function, steroid/thyroid hormone synthesis as well as receptor-mediated effects in mammals and other taxa. Chemicals positive in Tier 1 should be labeled as potential endocrine disrupters and subjected to testing (Tier 2). The present discussion will provide examples of in vitro (receptor binding, gene expression and steroidogenesis) and in vivo assays for screening. Short-term in vivo assays which have been used to detect estrogenicity for over 70 years are still useful in this regard. Identification of (anti)androgenic activity is easily accomplished by examination of growth of androgen-dependent tissues in young castrated male rats, determination of the age at puberty (balanopreputial separation) or by examination of reproductive malformations after in utero exposure (hypospadias, testicular non-descent, retained nipples, a vaginal pouch, prostate agenesis, and reduced anogenital distance). Pubertal assays with intact animals will not only detect chemicals that alter E-A function via their nuclear receptors, but also will detect altered hormone synthesis and alterations of the hypothalamic-pituitary-gonadal axis. While in utero assays are critical for testing, presently they are not included in screening because they can be relatively long-term studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10022334     DOI: 10.1016/s0378-4274(98)00287-2

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Failure to Launch: The Endocrine Disruptor Screening Program at the U.S. Environmental Protection Agency.

Authors:  Maricel V Maffini; Laura N Vandenberg
Journal:  Front Toxicol       Date:  2022-05-30

Review 2.  Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.

Authors:  Andrew K Hotchkiss; Cynthia V Rider; Chad R Blystone; Vickie S Wilson; Phillip C Hartig; Gerald T Ankley; Paul M Foster; Clark L Gray; L Earl Gray
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

3.  Endocrine profiling and prioritization of environmental chemicals using ToxCast data.

Authors:  David M Reif; Matthew T Martin; Shirlee W Tan; Keith A Houck; Richard S Judson; Ann M Richard; Thomas B Knudsen; David J Dix; Robert J Kavlock
Journal:  Environ Health Perspect       Date:  2010-09-08       Impact factor: 9.031

4.  Effects of early prepubertal exposure to bisphenol A on the onset of puberty, ovarian weights, and estrous cycle in female mice.

Authors:  Won Heum Nah; Mi Jung Park; Myung Chan Gye
Journal:  Clin Exp Reprod Med       Date:  2011-06-30

5.  Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Authors:  Huixiao Hong; Weida Tong; Hong Fang; Leming Shi; Qian Xie; Jie Wu; Roger Perkins; John D Walker; William Branham; Daniel M Sheehan
Journal:  Environ Health Perspect       Date:  2002-01       Impact factor: 9.031

6.  Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate.

Authors:  R W Moore; T A Rudy; T M Lin; K Ko; R E Peterson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

7.  Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.

Authors:  Hui Wen Ng; Wenqian Zhang; Mao Shu; Heng Luo; Weigong Ge; Roger Perkins; Weida Tong; Huixiao Hong
Journal:  BMC Bioinformatics       Date:  2014-10-21       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.